Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A French Nationwide Study of Ninety‐Two Patients

Objective Intravenous immunoglobulin (IVIG) represents a therapeutic alternative in antineutrophil cytoplasmic antibody–associated vasculitides (AAV), but its efficacy has been evaluated in only 2 small prospective trials. The aim of this study was to evaluate the efficacy and safety of IVIG in pati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2016-03, Vol.68 (3), p.702-712
Hauptverfasser:	Crickx, Etienne, Machelart, Irène, Lazaro, Estibaliz, Kahn, Jean‐Emmanuel, Cohen‐Aubart, Fleur, Martin, Thierry, Mania, Alexandre, Hatron, Pierre‐Yves, Hayem, Gilles, Blanchard‐Delaunay, Claire, de Moreuil, Claire, Le Guenno, Guillaume, Vandergheynst, Frédéric, Maurier, François, Crestani, Bruno, Dhote, Robin, Silva, Nicolas Martin, Ollivier, Yann, Mehdaoui, Anas, Godeau, Bertrand, Mariette, Xavier, Cadranel, Jacques, Cohen, Pascal, Puéchal, Xavier, Le Jeunne, Claire, Mouthon, Luc, Guillevin, Loïc, Terrier, Benjamin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adeno-associated virus Adolescent Adult Aged Aged, 80 and over Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy Antibodies, Antineutrophil Cytoplasmic - blood Cellular Biology Churg-Strauss Syndrome - drug therapy Corticosterone - administration & dosage Female Fluorescent Antibody Technique Humans Immune Tolerance Immunoglobulins Immunoglobulins, Intravenous - administration & dosage Immunoglobulins, Intravenous - adverse effects Immunoglobulins, Intravenous - pharmacology Immunomodulation Immunosuppressive Agents - administration & dosage Life Sciences Male Microscopic Polyangiitis - drug therapy Middle Aged Placebo effect Remission Induction Retrospective Studies Treatment Failure Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!